Paid Clinical Trials in Greensboro, NC
As of September 2026, 109 paid clinical trials are recruiting in Greensboro, North Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Greensboro offers studies at sites including Cone Health Cancer Center for conditions such as Obesity, Overweight, Heart Failure, Malignant Solid Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Greensboro
Trials by drug in Greensboro
Filter results
Newly added in Greensboro
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
99 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Prevail Global Study
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Top Research Study Locations in Greensboro
Researchers run research studies in Greensboro, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cone Health Cancer Center | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 17 |
| Cone Health Cancer Center at Drawbridge Parkway | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 12 |
| Medication Management | Overweight, Obesity, Atherosclerotic Cardiovascular Disease (ASCVD) | 6 |
| Headache Wellness Center | Acute Migraine, Acute Treatment of Migraine, Migraine | 5 |
| Moses H. Cone Memorial Hospital | Heart Failure, Acute Decompensated Heart Failure, Atrial Enlargement | 4 |
| Novant Health Breast Surgery - Greensboro | Breast Cancer, Cigarette Smoking-Related Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma | 4 |
| GSK Investigational Site | HIV Infections, Influenza, Human | 3 |
| Medication Management LLC | Cardiovascular Disease, Cardiovascular Disease and Lipoprotein(a), Obesity | 3 |
| Moses H Cone Memorial Hospital | Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Obesity | 3 |
| PharmQuest | Diabetes Mellitus, Type 2, Obesity, Overweight | 3 |
| Triad Clinical Trials | Alzheimers Disease, Tophaceous Gout | 3 |
| Carolina Kidney Associates | Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Focal Segmental Glomerulosclerosis | 2 |
| Moses H. Cone Memorial Hospital Operating Corporation d/b/a Cone Health | Heart Failure, Heart Failure With Reduced Ejection Fraction, Moderate Aortic Valve Stenosis | 2 |
| PharmQuest Life Sciences LLC | Diabetes Mellitus, Type 2, Obesity | 2 |
| PulmonIx, LLC | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Cancer | 2 |
| Triad Clinical Trials, LLC | Cardiovascular Disease, Uncontrolled Gout | 2 |
| UNC Greensboro | Active Citizenship, Aerobic Exercise, Anti-extremism | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 2 |
| PulmonIx LLC | Interstitial Lung Disease, Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | 2 |
| 3203 Greensboro CRS | HIV Infection, Menopause | 1 |
| 3203, Greensboro CRS | Acute HIV Infection | 1 |
| Clinical Research | Severe Hypertriglyceridemia | 1 |
| Cone Health | Breastfeeding Continuation, Breastfeeding Duration, Breastfeeding Self-Efficacy | 1 |
| Cone Health Advanced Heart Failure Clinic at Moses Cone | CKD Stage 3, Chronic Heart Failure | 1 |
| Cone Health Cancer Center at Wesley Long | Breast Cancer | 1 |
Active & Upcoming Studies in Greensboro (2026)
Recruiting trials in Greensboro grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors · Phase 3 · SWOG Cancer Research Network
- A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer · Phase 3 · UroGen Pharma Ltd.
Cardiovascular (16 active studies)
- REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease · HeartFlow, Inc.
- A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF) · Phase 2 · Edgewise Therapeutics, Inc.
Diabetes & metabolic (15 active studies)
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema · Phase 3 · Novo Nordisk A/S
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
Neurology & pain (7 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
HIV / STI (5 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- Menopausal HT for Women Living With HIV (HoT) · Phase 4 · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Eye & vision (3 active studies)
- Post-refractive IOL Outcomes With Clareon TruPlus · Laser Defined Vision
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Mental health & behavior (2 active studies)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
- Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program · Phase 3 · Alliance for Clinical Trials in Oncology
Vaccines (1 active study)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
Common conditions studied in Greensboro
- Obesity (9 active studies)
- Overweight (9 active studies)
- Heart Failure (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
- Breast Cancer (3 active studies)
- Diabetes Mellitus, Type 2 (3 active studies)
Leading research sponsors in Greensboro
- AstraZeneca
- Eli Lilly and Company
- National Cancer Institute (NCI)
- Novo Nordisk A/S
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Greensboro?
There are approximately 109 recruiting clinical trials in Greensboro, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Greensboro pay participants?
Most recruiting trials in Greensboro compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Greensboro?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Greensboro?
The most common conditions under active study in Greensboro include Obesity (9), Overweight (9), Heart Failure (4), Malignant Solid Neoplasm (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Greensboro?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Greensboro on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Greensboro?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Greensboro?
Recruiting research sites in Greensboro include Cone Health Cancer Center, Cone Health Cancer Center at Drawbridge Parkway, Medication Management, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Greensboro right now?
The largest active categories in Greensboro are Cancer & tumors (21), Cardiovascular (16), Diabetes & metabolic (15). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.